JunD proto-oncogene, AP-1 transcription factor subunit (JUND)

JunD proto-oncogene, AP-1 transcription factor subunit (JUND), is an intronless gene encoding a member of the Jun family of basic region-leucine zipper (bZIP) transcription factors[2][3]. JunD forms homodimers or heterodimers (with other Jun or Fos family proteins), participating in the AP-1 transcription factor complex, which regulates the expression of genes involved in cell growth, differentiation, apoptosis, and stress response[1][2][3]. JunD is unique among the Jun family for its ability to generate multiple protein isoforms by alternative translational initiation, which show differential transcriptional activity and protein–protein interaction profiles[1][2]. JunD helps regulate responses to oxidative stress, acts as a negative regulator of Ras-mediated cellular transformation, and protects against senescence and apoptosis. Aberrant JunD function or expression is implicated in various human diseases, including cancer, cardiovascular disease, and metabolic disorders[2][3]. While not an approved drug target, experimental manipulation (e.g., dominant negative ΔJunD) has been explored for scientific and therapeutic research, especially in the context of addiction biology and oncogenesis.

Other names

JunDAP-1Transcription factor AP-1 subunit JunDtranscription factor jun-DJunD-FLactivator protein 1jun D proto-oncogeneΔJunD (Delta JunD) [mutant isoform]

Not applicable for direct pharmacological targeting. For experimental interventions, ΔJunD acts as a dominant negative antagonist of AP-1 transcriptional activity, particularly opposing ΔFosB-mediated transcription.